Efavirenz · larger labeled portfolio than Tenofovir Disoproxil

SPL labels Tenofovir Disoproxil + Efavirenz as minor; Tenofovir Disoproxil 13 / Efavirenz 29 in that band.

Mechanism on file: These two medications do not interfere with each other in a way that changes how they work in your body.

FDA SPL severity: Minor

Tenofovir Disoproxil

Full Tenofovir Disoproxil label record

Nucleotide Reverse Transcriptase Inhibitor

Efavirenz

Full Efavirenz label record

NNRTI / NRTI Combination

Tenofovir Disoproxil + Efavirenz · SPL mechanism field

These two medications do not interfere with each other in a way that changes how they work in your body.

Minor band excerpt · Tenofovir Disoproxil with Efavirenz

7.5 Drugs Without Clinically Significant Interactions with Efavirenz No dosage adjustment is recommended when efavirenz is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lorazepam, nelfinavir, nucleoside reverse transcriptase inhibitors (abacavir, emtricitabine, lamivudine, stavudine, tenofovir disoproxil fumarate, zidovudine), paroxetine, and raltegravir.

Efavirenz · 32 SPL pairs (broader portfolio than Tenofovir Disoproxil)

View all Efavirenz interactions →

FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.